Hi Livas1 I gather it was more about the direction, ie SLA...

Hi Livas1 I gather it was more about the direction, ie SLA thought resources could have been put into BIO A R&D, and maybe also viewed as a competitor to BIO cosmetic products in some markets. Spat done and dusted IMO - in perspective the R&D cost possibly only relatively the same as say - one director's ongoing remuneration. Overhauled RE-GEN product range to be available locally shortly - ahead of China down the track, tapering marketing costs.